If you are a non-U.S. medical device manufacturer, appointing a U.S. Agent and FDA Official Correspondent is not optional—it is a regulatory requirement for entering and maintaining access to the U.S. market.
RQMIS provides reliable, responsive representation to ensure your organization stays compliant, connected, and prepared for FDA interaction at every stage.
Before you can legally market medical devices in the United States, your establishment must:
Without a U.S. Agent, your registration cannot be completed—and your products cannot be imported into the U.S.
At the same time, every registered establishment must assign an Official Correspondent responsible for managing FDA communications and maintaining registration accuracy.
Together, these roles ensure that the FDA has a reliable, responsive point of contact for your organization.
A U.S. Agent is your FDA-designated representative based in the United States.
This role is required for all foreign manufacturers and serves as the primary communication bridge between your company and the FDA.
The U.S. Agent must:
The Official Correspondent (OC) is responsible for managing your establishment registration and device listings with the FDA.
The OC plays a critical role in ensuring your regulatory information is accurate, current, and inspection-ready.
While these roles often overlap, they serve distinct functions:
In many cases, companies choose a single partner to fulfill both roles—streamlining communication and reducing risk.
An unresponsive or poorly managed U.S. Agent or Official Correspondent can lead to:
In high-stakes situations—such as warning letters or inspections—timely communication is critical.
RQMIS provides dependable U.S. Agent and Official Correspondent services designed to keep your organization compliant and responsive.
We act as your dedicated point of contact for FDA inquiries, ensuring all communications are received, reviewed, and routed without delay.
With RQMIS, you can:
When it comes to FDA communication, speed and accuracy matter.